1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Mixed Tumor, Mesodermal: new trials by email Literature Review of Mixed Tumor, Mesodermal trials Research Report on Mixed Tumor, Mesodermal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer Paclitaxel, Carboplatin - Ovarian Cancer, Primary Peritoneal Carcinoma | Phase 2 | Terminated | Dana-Farber Cancer Institute | 12 | 2006-04-01 | 2018-09-10 |
| Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus Ifosfamide, Radiation Therapy, Cisplatin - Uterine Cancer | Phase 2 | Completed | Montefiore Medical Center | 30 | 2003-02-01 | 2019-01-23 |
Fallopian Tube Neoplasms (1) · Ovarian Neoplasms (1) · Uterine Neoplasms (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Complex and Mixed (2) · Neoplasms, Connective and Soft Tissue (2) · Sarcoma (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Adnexal Diseases (1) · Endocrine Gland Neoplasms (1)
Carboplatin (1) · Cisplatin (1) · Ifosfamide (1) · Paclitaxel (1) · Radiotherapy (1)
Dana-Farber Cancer Institute (1) · Montefiore Medical Center (1)
United States (2)
Mark H Einstein, M.D., M.S. (1) · Ursula Matulonis, MD (1)